iBio Inc (IBIO)
1.91
+0.01
(+0.53%)
USD |
NYAM |
Apr 24, 09:42
iBio Enterprise Value: 16.49M for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 23, 2024 | 16.49M |
April 22, 2024 | 16.07M |
April 19, 2024 | 15.86M |
April 18, 2024 | 16.03M |
April 17, 2024 | 16.45M |
April 16, 2024 | 16.66M |
April 15, 2024 | 16.59M |
April 12, 2024 | 16.91M |
April 11, 2024 | 16.80M |
April 10, 2024 | 16.91M |
April 09, 2024 | 17.43M |
April 08, 2024 | 17.74M |
April 05, 2024 | 17.22M |
April 04, 2024 | 18.54M |
April 03, 2024 | 20.11M |
April 02, 2024 | 19.83M |
April 01, 2024 | 21.54M |
March 28, 2024 | 24.01M |
March 27, 2024 | 21.57M |
March 26, 2024 | 13.87M |
March 25, 2024 | 13.68M |
March 22, 2024 | 13.66M |
March 21, 2024 | 13.63M |
March 20, 2024 | 13.60M |
March 19, 2024 | 13.56M |
Date | Value |
---|---|
March 18, 2024 | 13.53M |
March 15, 2024 | 13.53M |
March 14, 2024 | 13.84M |
March 13, 2024 | 13.91M |
March 12, 2024 | 13.91M |
March 11, 2024 | 13.98M |
March 08, 2024 | 13.98M |
March 07, 2024 | 13.98M |
March 06, 2024 | 14.05M |
March 05, 2024 | 14.12M |
March 04, 2024 | 14.22M |
March 01, 2024 | 14.19M |
February 29, 2024 | 14.26M |
February 28, 2024 | 14.08M |
February 27, 2024 | 13.94M |
February 26, 2024 | 14.01M |
February 23, 2024 | 14.05M |
February 22, 2024 | 14.05M |
February 21, 2024 | 13.98M |
February 20, 2024 | 14.26M |
February 16, 2024 | 14.26M |
February 15, 2024 | 14.12M |
February 14, 2024 | 14.08M |
February 13, 2024 | 14.12M |
February 12, 2024 | 14.08M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.373M
Minimum
Nov 27 2019
843.20M
Maximum
Jul 20 2020
92.63M
Average
34.90M
Median
Enterprise Value Benchmarks
Lixte Biotechnology Holdings Inc | 6.539M |
PAVmed Inc | 74.52M |
Avalo Therapeutics Inc | 5.997M |
Imunon Inc | -3.288M |
Ocugen Inc | 285.00M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -8.211M |
Total Expenses (Quarterly) | 4.496M |
EPS Diluted (Quarterly) | -4.42 |
Earnings Yield | -786.4% |
Normalized Earnings Yield | -1934.03 |